. 2018 Dec 21;38(6):BSR20181304. doi: 10.1042/BSR20181304

Table 4. Treatment efficacy assessed by B-mode ultrasound, HbA1C, and ALT (n(%)).

Group	Non-NAFLD	NAFLD	HbA1C <7	HbA1C >7	ALT <40	ALT >40
Lira group	11	41	19	33	29	23
(n=52)	21.2%	78.8%	36.5%	63.5%	55.8%	44.2%
Met group	8	67	33	42	20	55
(n=75)	10.7%	89.3%	44%	56%	26.7%	73.3%
χ²	2.35		0.24		9.86
P	0.13		0.62		0.02